Cestex 25 mg, 100 Tablets

View Cestex Drug Facts Sheet.

Cestex tablets should be adminis-tered orally. The recommended dosage of epsiprantel is: cats, 1.25 mg/lb of body weight; dogs, 2.5 mg/lb of body weight. The following table may be used as a guide:

Fasting is not necessary or recommended.

Unless exposure to the infected intermediate hosts is controlled, reinfection is likely and retreatment may be required. In the case of D. caninum, an effective flea control program should be instituted.

Caution:

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Contraindications:

There are no known contraindications to the use of this drug.

Warnings:

For use in cats and dogs only. Safety of use in pregnant or breeding animals has not been determined. Keep out of reach of children. Not for use in humans.

Precaution:

Do not use in kittens or puppies less than 7 weeks of age.

Safety:

Epsiprantel has been evaluated in cats at 5 times the recom-mended dose given once daily for 3 days with no adverse effects noted. In tolerance studies, epsiprantel produced minimal clinical signs in cats given 40 times the recommended dose once daily for 4 days.

Epsiprantel has been evaluated in 14-day repeat dose studies in dogs at 500 mg/kg (90 times recommended dosage) with no significant adverse results. No side effects were observed during the clinical field studies.

Epsiprantel is not a cholinesterase inhibitor. During the course of clinical field studies, Cestex was administered concurrently with diethylcarbamazine citrate (dogs only), anti-inflammatory agents, insecticides, and nematocides with no drug incompatibilities noted.

Possible Side Effects

No side effects were observed during clinical field trials. In very rare instances, vomiting or diarrhea may occur. Talk to your veterinarian about any side effect that seems unusual or bothersome to the animal.

Storage:

Store at controlled room temperature 20°-25°C (68°-77°F) with excursions between 15°-30°C (59°-86°F).